GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regeneron Pharmaceuticals Inc (LTS:0R2M) » Definitions » E10

Regeneron Pharmaceuticals (LTS:0R2M) E10 : $30.65 (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Regeneron Pharmaceuticals E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Regeneron Pharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2024 was $11.540. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $30.65 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Regeneron Pharmaceuticals's average E10 Growth Rate was 16.30% per year. During the past 3 years, the average E10 Growth Rate was 35.80% per year. During the past 5 years, the average E10 Growth Rate was 40.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Regeneron Pharmaceuticals was 156.60% per year. The lowest was -9.00% per year. And the median was 5.70% per year.

As of today (2024-12-11), Regeneron Pharmaceuticals's current stock price is $778.60. Regeneron Pharmaceuticals's E10 for the quarter that ended in Sep. 2024 was $30.65. Regeneron Pharmaceuticals's Shiller PE Ratio of today is 25.40.

During the past 13 years, the highest Shiller PE Ratio of Regeneron Pharmaceuticals was 4276.40. The lowest was 23.88. And the median was 57.48.


Regeneron Pharmaceuticals E10 Historical Data

The historical data trend for Regeneron Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regeneron Pharmaceuticals E10 Chart

Regeneron Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.59 11.00 19.54 23.33 27.37

Regeneron Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.59 27.37 28.55 29.80 30.65

Competitive Comparison of Regeneron Pharmaceuticals's E10

For the Biotechnology subindustry, Regeneron Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regeneron Pharmaceuticals's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regeneron Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Regeneron Pharmaceuticals's Shiller PE Ratio falls into.



Regeneron Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Regeneron Pharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=11.54/133.0289*133.0289
=11.540

Current CPI (Sep. 2024) = 133.0289.

Regeneron Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201412 0.960 99.070 1.289
201503 0.660 99.621 0.881
201506 1.690 100.684 2.233
201509 1.820 100.392 2.412
201512 1.340 99.792 1.786
201603 1.590 100.470 2.105
201606 1.690 101.688 2.211
201609 2.270 101.861 2.965
201612 2.190 101.863 2.860
201703 2.160 102.862 2.793
201706 3.340 103.349 4.299
201709 3.320 104.136 4.241
201712 1.500 104.011 1.918
201803 4.160 105.290 5.256
201806 4.820 106.317 6.031
201809 5.170 106.507 6.457
201812 7.150 105.998 8.973
201903 3.990 107.251 4.949
201906 1.680 108.070 2.068
201909 5.860 108.329 7.196
201912 6.930 108.420 8.503
202003 5.430 108.902 6.633
202006 7.610 108.767 9.307
202009 7.390 109.815 8.952
202012 10.240 109.897 12.395
202103 10.090 111.754 12.011
202106 27.970 114.631 32.459
202109 14.330 115.734 16.471
202112 19.690 117.630 22.268
202203 8.610 121.301 9.442
202206 7.470 125.017 7.949
202209 11.660 125.227 12.386
202212 10.500 125.222 11.155
202303 7.170 127.348 7.490
202306 8.500 128.729 8.784
202309 8.890 129.860 9.107
202312 10.190 129.419 10.474
202403 6.270 131.776 6.330
202406 12.410 132.554 12.454
202409 11.540 133.029 11.540

Add all the adjusted EPS together and divide 10 will get our e10.


Regeneron Pharmaceuticals  (LTS:0R2M) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Regeneron Pharmaceuticals's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=778.60/30.65
=25.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Regeneron Pharmaceuticals was 4276.40. The lowest was 23.88. And the median was 57.48.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Regeneron Pharmaceuticals E10 Related Terms

Thank you for viewing the detailed overview of Regeneron Pharmaceuticals's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Regeneron Pharmaceuticals Business Description

Address
777 Old Saw Mill River Road, Tarrytown, NY, USA, 10591-6707
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

Regeneron Pharmaceuticals Headlines

No Headlines